当前蛋白身份:P08179 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1C2T NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTURE AND NMR STUDIES OF E. COLI GAR TRANSFORMYLASE IN COMPLEX WITH BETA-GAR AND 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID. 提交 1999-07-26 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
链 B 1–212(212 aa)
未记录 NHS 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID × 2 GAR GLYCINAMIDE RIBONUCLEOTIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;295 K;PEG 3350, IMIDAZOLE MALATE, CALCIUM CHLORIDE, MPD, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 22.0K, temperature 295K
分辨率 2.10 Å R-free 0.265
1C3E NEW INSIGHTS INTO INHIBITOR DESIGN FROM THE CRYSTAL STRUCTURE AND NMR STUDIES OF E. COLI GAR TRANSFORMYLATE IN COMPLEX WITH BETA-GAR AND 10-FORMYL-5,8,10-TRIDEAZAFOLIC ACID. 提交 1999-07-27 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 未唯一映射 参考区间未声明
链 A 1–209(209 aa)
未记录 NHR 2-{4-[2-(2-AMINO-4-HYDROXY-QUINAZOLIN-6-YL)-1-CARBOXY-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID × 2 GAR GLYCINAMIDE RIBONUCLEOTIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.2;295 K;PEG 3350, Imidazole malate, calcium chloride, MPD, pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 22.0K
分辨率 2.10 Å R-free 0.263
1CDD STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
链 B 1–212(212 aa)
未记录 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.80 Å
1CDD STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
链 B 1–212(212 aa)
未记录 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.80 Å
1CDE STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–212(212 aa)
未记录 GAR GLYCINAMIDE RIBONUCLEOTIDE × 1 DZF 5-DEAZAFOLIC ACID × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å
1CDE STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–212(212 aa)
未记录 GAR GLYCINAMIDE RIBONUCLEOTIDE × 1 DZF 5-DEAZAFOLIC ACID × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å
1CDE STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 3 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 C 1–212(212 aa)
未记录 GAR GLYCINAMIDE RIBONUCLEOTIDE × 1 DZF 5-DEAZAFOLIC ACID × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å
1CDE STRUCTURES OF APO AND COMPLEXED ESCHERICHIA COLI GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1992-05-15 Assembly 4 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 D 1–212(212 aa)
未记录 GAR GLYCINAMIDE RIBONUCLEOTIDE × 1 DZF 5-DEAZAFOLIC ACID × 1 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å
1GAR TOWARDS STRUCTURE-BASED DRUG DESIGN: CRYSTAL STRUCTURE OF A MULTISUBSTRATE ADDUCT COMPLEX OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE AT 1.96 ANGSTROMS RESOLUTION 提交 1994-12-08 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
链 B 1–212(212 aa)
未记录 U89 N-[4-[[3-(2,4-DIAMINO-1,6-DIHYDRO-6-OXO-4-PYRIMIDINYL)-PROPYL]-[2-((2-OXO-2-((4-PHOSPHORIBOXY)-BUTYL)-AMINO)-ETHYL)-THIO-ACETYL]-AMINO]BENZOYL]-1-GLUTAMIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.96 Å R-free 0.290
1GRC CRYSTAL STRUCTURE OF GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE FROM ESCHERICHIA COLI AT 3.0 ANGSTROMS RESOLUTION: A TARGET ENZYME FOR CHEMOTHERAPY 提交 1992-07-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
链 B 1–212(212 aa)
未记录 PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 3.00 Å
1JKX Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase 提交 2001-07-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa) 片段:TRANSFERASE
链 B 1–212(212 aa) 片段:TRANSFERASE
未记录 138 N-[5'-O-PHOSPHONO-RIBOFURANOSYL]-2-[2-HYDROXY-2-[4-[GLUTAMIC ACID]-N-CARBONYLPHENYL]-3-[2-AMINO-4-HYDROXY-QUINAZOLIN-6-YL]-PROPANYLAMINO]-ACETAMIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;295 K;PEG 3350, CaCl2, MPD, imidazole malate, PH 7.4, VAPOR DIFFUSION, SITTING DROP at 295K
分辨率 1.60 Å R-free 0.243
1JKX Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase 提交 2001-07-13 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 C 1–212(212 aa) 片段:TRANSFERASE
链 D 1–212(212 aa) 片段:TRANSFERASE
未记录 138 N-[5'-O-PHOSPHONO-RIBOFURANOSYL]-2-[2-HYDROXY-2-[4-[GLUTAMIC ACID]-N-CARBONYLPHENYL]-3-[2-AMINO-4-HYDROXY-QUINAZOLIN-6-YL]-PROPANYLAMINO]-ACETAMIDE × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.4;295 K;PEG 3350, CaCl2, MPD, imidazole malate, PH 7.4, VAPOR DIFFUSION, SITTING DROP at 295K
分辨率 1.60 Å R-free 0.243
2GAR A PH-DEPENDENT STABLIZATION OF AN ACTIVE SITE LOOP OBSERVED FROM LOW AND HIGH PH CRYSTAL STRUCTURES OF MUTANT MONOMERIC GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1998-05-13 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–212(212 aa)
突变:E70A PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 pH 3.5;CRYSTAL GREW FROM A SOLUTION OF 2%(V/V) 15% (W/V) PEG 1500, PH 3.5
分辨率 1.80 Å R-free 0.251
3GAR A PH-DEPENDENT STABLIZATION OF AN ACTIVE SITE LOOP OBSERVED FROM LOW AND HIGH PH CRYSTAL STRUCTURES OF MUTANT MONOMERIC GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE 提交 1998-05-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–212(212 aa)
突变:E70A PO4 PHOSPHATE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.5;CRYSTAL GREW FROM A SOLUTION OF 2%(V/V) PEG 400. 2.0M AMMONIUM SULFATE, 0.1M HEPES, PH 7.5
分辨率 1.90 Å R-free 0.274